Ileal Crohn’s disease: CEUS determination of activity

[1]  L. Guidi,et al.  Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activity. , 2012, Radiology.

[2]  F. Tacke,et al.  Assessment of Inflammatory and Fibrotic Stenoses in Patients with Crohn’s Disease Using Contrast-Enhanced Ultrasound and Computerized Algorithm: A Pilot Study , 2011, Digestion.

[3]  P. Burns,et al.  Microbubble-enhanced US in body imaging: what role? , 2010, Radiology.

[4]  E. Jung,et al.  Comparison between Preoperative Quantitative Assessment of Bowel Wall Vascularization by Contrast-Enhanced Ultrasound and Operative Macroscopic Findings and Results of Histopathological Scoring in Crohn’s Disease , 2010, Ultraschall in der Medizin.

[5]  P. Rutgeerts,et al.  Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. , 2010, Gastroenterology.

[6]  L. Flors,et al.  Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy. , 2009, Radiology.

[7]  P. Rutgeerts,et al.  Mucosal healing predicts long‐term outcome of maintenance therapy with infliximab in Crohn's disease , 2009, Inflammatory bowel diseases.

[8]  E. Quaia,et al.  Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn's disease. , 2009, Gastroenterology.

[9]  J. Fletcher,et al.  CT enterography: principles, technique and utility in Crohn's disease. , 2009, European journal of radiology.

[10]  H. Siddiki,et al.  MR imaging of the small bowel in Crohn's disease. , 2009, European journal of radiology.

[11]  M. Cova,et al.  The diagnostic value of small bowel wall vascularity after sulfur hexafluoride-filled microbubble injection in patients with Crohn's disease. Correlation with the therapeutic effectiveness of specific anti-inflammatory treatment. , 2009, European journal of radiology.

[12]  J. Domjan,et al.  Is there an association between intestinal perfusion and Crohn's disease activity? A feasibility study using contrast-enhanced ultrasound. , 2009, The British journal of radiology.

[13]  W. Kratzer,et al.  Comparison of sonographically measured bowel wall vascularity, histology, and disease activity in Crohn’s disease , 2009, European Radiology.

[14]  M. Daperno,et al.  Abdominal bowel ultrasound can predict the risk of surgery in Crohn's disease: Proposal of an ultrasonographic score , 2009, Scandinavian journal of gastroenterology.

[15]  E. Quaia,et al.  Inflammatory activity in Crohn disease: ultrasound findings , 2008, Abdominal Imaging.

[16]  K. Matre,et al.  Crohn's disease: Comparison of in vitro ultrasonographic images and histology , 2008, Scandinavian journal of gastroenterology.

[17]  P. Gionchetti,et al.  Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn's disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent. , 2007, European journal of radiology.

[18]  Emilio Quaia,et al.  Microbubble ultrasound contrast agents: an update , 2007, European Radiology.

[19]  L. Bolondi,et al.  The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. , 2006, Ultrasound in medicine & biology.

[20]  J. Satsangi,et al.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications , 2006, Gut.

[21]  F. Castiglione,et al.  Bowel sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease , 2006, Inflammatory bowel diseases.

[22]  E. Louis,et al.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. , 2006, Journal of Crohn's & colitis.

[23]  G. Casazza,et al.  Role of US in detection of Crohn disease: meta-analysis. , 2005, Radiology.

[24]  G. Torzilli.  Adverse effects associated with SonoVue® use , 2005, Expert opinion on drug safety.

[25]  W. Kratzer,et al.  Contrast-enhanced wideband harmonic imaging ultrasound (SonoVue®): A new technique for quantifying bowel wall vascularity in Crohn's disease , 2005, Scandinavian journal of gastroenterology.

[26]  Ç. Karaca,et al.  Crohn Disease Activity Evaluated by Doppler Ultrasonography of the Superior Mesenteric Artery and the Affected Small‐Bowel Segments , 2005, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[27]  F. Manguso,et al.  Bowel Wall Thickness at Abdominal Ultrasound and the One-Year-Risk of Surgery in Patients with Crohn's Disease , 2004, American Journal of Gastroenterology.

[28]  M. Zalis,et al.  Imaging of Inflammatory Bowel Disease: CT and MR , 2004, Digestive Diseases.

[29]  M. Astegiano,et al.  Activity of Crohn disease: value of Color-Power-Doppler and contrast-enhanced ultrasonography , 2004, Abdominal Imaging.

[30]  M. Pompili,et al.  Contrast‐enhanced power Doppler of the intestinal wall in the evaluation of patients with Crohn disease , 2004, Scandinavian journal of gastroenterology.

[31]  G. Porro,et al.  Small bowel stenosis in Crohn's disease: clinical, biochemical and ultrasonographic evaluation of histological features , 2003, Alimentary pharmacology & therapeutics.

[32]  G. Porro,et al.  Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn's disease: a prospective comparative study. , 2003 .

[33]  G. Porro,et al.  Bowel ultrasound in assessment of Crohn's disease and detection of related small bowel strictures: a prospective comparative study versus x ray and intraoperative findings , 2002, Gut.

[34]  J. Varghese,et al.  Assessment of Crohn's disease activity by Doppler sonography of the superior mesenteric artery, clinical evaluation and the Crohn's disease activity index: a prospective study. , 2001, Clinical radiology.

[35]  G. Corazza,et al.  Doppler Enhancement After Intravenous Levovist Injection in Crohn's Disease , 2001, Inflammatory bowel diseases.

[36]  M. Dubinsky,et al.  Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity. , 2000, Radiology.

[37]  E. Stange,et al.  Mesenteric blood flow is related to disease activity and risk of relapse in Crohn's disease: a prospective follow-up study , 1999, American Journal of Gastroenterology.

[38]  B. Limberg.  [Diagnosis of chronic inflammatory bowel disease by ultrasonography]. , 1999, Zeitschrift fur Gastroenterologie.

[39]  K. Turetschek,et al.  Transabdominal bowel sonography for the detection of intestinal complications in Crohn’s disease , 1999, Gut.

[40]  B. Cesana,et al.  Abdominal ultrasound in the assessment of extent and activity of Crohn's disease: clinical significance and implication of bowel wall thickening. , 1996, The American journal of gastroenterology.

[41]  F. T. ten Cate,et al.  Adverse reactions after the use of sulphur hexafluoride (SonoVue) echo contrast agent. , 2009, Journal of cardiovascular medicine.

[42]  E. Jung,et al.  Quantitative assessment of bowel wall vascularisation in Crohn's disease with contrast-enhanced ultrasound and perfusion analysis. , 2009, Clinical hemorheology and microcirculation.

[43]  E. Jung,et al.  Microcirculation and perfusion with contrast enhanced ultrasound (CEUS) in Crohn's disease: first results with linear contrast harmonic imaging (CHI). , 2008, Clinical hemorheology and microcirculation.

[44]  L. Guidi,et al.  Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn's disease. , 2006, European review for medical and pharmacological sciences.

[45]  M. Mínguez,et al.  Activity of Crohn's disease assessed by colour Doppler ultrasound analysis of the affected loops , 2001, European Radiology.